Leuprolide API Manufacturers
compare suppliers & send inquiries for free
Country of origin
Established in: 2019
MOQ: 1 g
Focused on pharmaceutical industry
Reasonable price for the customers
Full service from R&D stage to commercial stage
Established in: 2013
MOQ: 1 kg
Drug R&D center (in Hangzhou)
From lab scale (mg/g) to commercial scale (kgs/tons)
Established in: 1944
14 international API plant sites
Portfolio of 350+ APIs
Teva is among the world’s largest generic drug/API manufacturers
How does it work?
You can register for free as long as you are registering on behalf of a legal company related to the pharmaceutical industry
Search in the search bar the product that you’re looking for. We’ll show you an overview of all available suppliers. Use the filters to select the relevant suppliers only
Have you found interesting suppliers? Then it’s time to contact them. Use the send inquiry button and send them a message. You can send for each product, 3 inquiries per week
Suppliers get notified by Pharmaoffer that they’ve received a new inquiry. They will come back to you with their questions, certificates, and offer in the chat on Pharmaoffer. We will send you an email in case of any news
Does the supplier meet your quality and commercial requirements? Then you can place the order. Just follow the steps of our order module
Looking for Leuprolide API 53714-56-0?
- Here you will find a list of producers, manufacturers and traders of Leuprolide. You can sort by certificates such as GMP, FDA, CEP, Written Confirmation and more. Send inquiries for free and get in direct contact with the supplier of your choice.
- API | Excipient name:
- Leuprorelin , Leuprorelina , Leuproreline , Leuprorelinum , Leuprorelin , Leuprorelin
- Cas Number:
- DrugBank number:
- Unique Ingredient Identifier:
More information about this product: Leuprolide is a synthetic 9-residue peptide analogue of gonadotropin-releasing hormone (GnRH). Unlike the endogenous decapeptide GnRH, leuprolide contains a single D-amino acid (D-leucyl) residue, which helps to increase its circulating half-life from three to four minutes to approximately three hours. As a GnRH mimic, leuprolide is capable of binding to the GnRH receptor (GnRHR) and inducing downstream modulation of both gonadotropin hormone and sex steroid levels. Prolonged activation of GnRHR results in significant downregulation of sex steroid levels, which is primarily responsible for the clinical efficacy of leuprolide in diverse conditions, including advanced prostate cancer, endometriosis, and central precocious puberty Leuprolide was first approved in 1985 as a daily subcutaneous injection under the tradename Lupron™ by Abbvie Endocrine Inc.
Check who is selling Leuprolide in the overview above.
Leuprolide is a type of Gonadorelin agonists
Gonadorelin agonists belong to the subcategory of pharmaceutical active pharmaceutical ingredients (APIs) that play a crucial role in reproductive medicine. These compounds are designed to mimic the activity of gonadotropin-releasing hormone (GnRH), a hormone responsible for the regulation of reproductive function.
Gonadorelin agonists work by binding to and activating GnRH receptors in the pituitary gland. This results in the release of luteinizing hormone (LH) and follicle-stimulating hormone (FSH), which are essential for the normal functioning of the reproductive system.
These pharmaceutical agents have a wide range of applications, primarily in the field of assisted reproductive technology (ART) and hormone-related disorders. They are commonly used in the treatment of infertility, endometriosis, and precocious puberty. In ART, gonadorelin agonists are employed to stimulate the ovaries and induce ovulation, increasing the chances of successful conception during in vitro fertilization (IVF) procedures.
Gonadorelin agonists are available in different formulations, including injectables and nasal sprays, allowing for flexible administration based on individual patient needs. They are generally well-tolerated, with common side effects including headache, hot flashes, and mild injection site reactions.
Overall, gonadorelin agonists are critical components in the field of reproductive medicine, assisting in the management of various fertility-related conditions. With their targeted action on the GnRH receptors, these pharmaceutical APIs continue to contribute to advancements in assisted reproduction and the overall well-being of patients.
Leuprolide (Gonadorelin agonists), classified under Hormonal Agents
Hormonal agents are a prominent category of pharmaceutical active pharmaceutical ingredients (APIs) widely used in the medical field. These substances play a crucial role in regulating and modulating hormonal functions within the body. Hormonal agents are designed to mimic or manipulate the effects of naturally occurring hormones, allowing healthcare professionals to treat various endocrine disorders and hormonal imbalances.
Hormonal agents are commonly employed in the treatment of conditions such as hypothyroidism, hyperthyroidism, diabetes, and hormonal cancers. These APIs work by interacting with specific hormone receptors, either by stimulating or inhibiting their activity, to restore the balance of hormones in the body. They can be administered orally, intravenously, or through other routes depending on the specific medication and patient needs.
Pharmaceutical companies employ rigorous manufacturing processes and quality control measures to ensure the purity, potency, and safety of hormonal agent APIs. These APIs are synthesized using chemical or biotechnological methods, often starting from natural hormone sources or through recombinant DNA technology. Stringent regulatory guidelines are in place to guarantee the efficacy and safety of hormonal agent APIs, ensuring that patients receive high-quality medications.
As the demand for hormone-related therapies continues to grow, ongoing research and development efforts focus on enhancing the effectiveness and reducing the side effects of hormonal agent APIs. This includes the exploration of novel delivery systems, advanced formulations, and targeted drug delivery methods. By continuously advancing our understanding and capabilities in hormonal agents, the medical community can improve patient outcomes and quality of life for individuals with hormonal disorders.
Leuprolide manufacturers | traders | suppliers
We have 14 companies offering Leuprolide from 7 different countries.
Get in contact with the supplier of your choice:
- Apino Pharma Co., Ltd. from China
- SENOVA Technology Co., Ltd. from China
- BCN Peptides from Spain
- AMBIOPHARM from United States
- Chinese Peptide from China
- Teva API from Israel
- Hemmo Pharma from India
- Socosur from France
- Chemi S.p.A. from Italy
- Takeda Pharma from Japan
- Mylan from India
- Mallinckrodt from United States
- Polypeptide Labs from Sweden
- Sun Pharma from India
Let the supplier know whether you are looking for a product with a specific monograph such as EP (Ph. Eur.), USP, JP, BP or another quality. Or, whether you are looking for hydrochloride (HCl), anhydricum, base, micronisatum or a specific purity.
You can use the filters to find high-quality suppliers. For example, you can select GMP, FDA or ISO certified suppliers. Visit our FAQ page or use the chat box in the corner to get more information about Pharmaoffer.